Urinary leak after partial nephrectomy: Insights from a cohort with hereditary, multifocal, and reoperative cases

IF 2.3 3区 医学 Q3 ONCOLOGY Urologic Oncology-seminars and Original Investigations Pub Date : 2025-08-01 Epub Date: 2025-04-02 DOI:10.1016/j.urolonc.2025.03.013
Ruben Blachman-Braun M.D., Milan Patel, Lauren Loebach, Braden Millan M.D., Jaskirat Saini M.D., Sandeep Gurram M.D., W. Marston Linehan M.D., Mark W. Ball M.D.
{"title":"Urinary leak after partial nephrectomy: Insights from a cohort with hereditary, multifocal, and reoperative cases","authors":"Ruben Blachman-Braun M.D.,&nbsp;Milan Patel,&nbsp;Lauren Loebach,&nbsp;Braden Millan M.D.,&nbsp;Jaskirat Saini M.D.,&nbsp;Sandeep Gurram M.D.,&nbsp;W. Marston Linehan M.D.,&nbsp;Mark W. Ball M.D.","doi":"10.1016/j.urolonc.2025.03.013","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>To identify risk factors, surgical considerations, and management strategies associated with urinary leak (UL) following partial nephrectomy (PN) in a cohort that includes a significant number of patients with hereditary renal cancer syndromes, multiple tumors, and a history of prior PNs.</div></div><div><h3>Material and methods</h3><div>A retrospective chart review was conducted selecting patients who underwent PN at our institution from January 2006 to December 2023 was performed. Clinical, demographic, surgical characteristics, and management strategies were recorded and analyzed.</div></div><div><h3>Results</h3><div>A total of 1,173 PNs were analyzed, of those 89(7.6%) had a UL. Patients had a median age at surgery of 50[38-59] years, 3[1-6] tumors removed per procedure with a total of 5,947 tumors were removed, 61.6% PN via the robotic approach, and the most common diagnosis was von Hippel-Lindau disease (47.4%). The frequency of UL was 5.1% for first-time PN, 10.4% for second, and 19.6% for third. An increased risk of UL was observed with higher EBL (OR = 1.016; <em>P</em> = 0.006) and decrease with robotic approach (OR = 0.376; <em>P</em> &lt; 0.001). Overall, 44.9% of UL cases were successfully managed with conservative management (postop drain and Foley), while 98.9% were successfully managed with conservative management, ureteral stent placement, percutaneous drain, or nephrostomy tube.</div></div><div><h3>Conclusion</h3><div>UL is directly associated with the complexity of the surgery. The advantages of robotic-assisted surgery in reducing UL risk indicate potential avenues for improved outcomes. Future efforts should explore the role of intraoperative and postoperative strategies to minimize this complication. Conservative management and drain or catheter placement resolve most of the ULs.</div></div>","PeriodicalId":23408,"journal":{"name":"Urologic Oncology-seminars and Original Investigations","volume":"43 8","pages":"Pages 470.e11-470.e18"},"PeriodicalIF":2.3000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology-seminars and Original Investigations","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1078143925001139","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

To identify risk factors, surgical considerations, and management strategies associated with urinary leak (UL) following partial nephrectomy (PN) in a cohort that includes a significant number of patients with hereditary renal cancer syndromes, multiple tumors, and a history of prior PNs.

Material and methods

A retrospective chart review was conducted selecting patients who underwent PN at our institution from January 2006 to December 2023 was performed. Clinical, demographic, surgical characteristics, and management strategies were recorded and analyzed.

Results

A total of 1,173 PNs were analyzed, of those 89(7.6%) had a UL. Patients had a median age at surgery of 50[38-59] years, 3[1-6] tumors removed per procedure with a total of 5,947 tumors were removed, 61.6% PN via the robotic approach, and the most common diagnosis was von Hippel-Lindau disease (47.4%). The frequency of UL was 5.1% for first-time PN, 10.4% for second, and 19.6% for third. An increased risk of UL was observed with higher EBL (OR = 1.016; P = 0.006) and decrease with robotic approach (OR = 0.376; P < 0.001). Overall, 44.9% of UL cases were successfully managed with conservative management (postop drain and Foley), while 98.9% were successfully managed with conservative management, ureteral stent placement, percutaneous drain, or nephrostomy tube.

Conclusion

UL is directly associated with the complexity of the surgery. The advantages of robotic-assisted surgery in reducing UL risk indicate potential avenues for improved outcomes. Future efforts should explore the role of intraoperative and postoperative strategies to minimize this complication. Conservative management and drain or catheter placement resolve most of the ULs.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肾部分切除术后尿漏:来自遗传性、多灶性和再手术病例队列的见解。
目的:在一组包括大量遗传性肾癌综合征、多发性肿瘤和既往PNs病史的患者的队列中,确定与部分肾切除术(PN)后尿漏(UL)相关的危险因素、手术考虑和管理策略。材料和方法:选取2006年1月至2023年12月在我院行PN手术的患者进行回顾性图表回顾。记录和分析临床、人口统计学、手术特点和治疗策略。结果:共分析1173例PNs,其中89例(7.6%)发生UL。患者手术时中位年龄为50[38-59]岁,每次手术切除肿瘤3[1-6]个,共切除肿瘤5,947个,61.6%的PN通过机器人入路,最常见的诊断为von Hippel-Lindau病(47.4%)。第一次PN的UL频率为5.1%,第二次为10.4%,第三次为19.6%。EBL越高,发生UL的风险越高(OR = 1.016;P = 0.006),机器人入路后下降(OR = 0.376;P < 0.001)。总体而言,44.9%的UL病例通过保守治疗(术后引流和Foley)成功治疗,而98.9%的患者通过保守治疗、输尿管支架置入术、经皮引流或肾造口管成功治疗。结论:UL与手术复杂性有直接关系。机器人辅助手术在降低UL风险方面的优势表明了改善结果的潜在途径。未来的努力应探讨术中和术后策略的作用,以尽量减少这种并发症。保守治疗和引流或置管可解决大多数ULs。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.80
自引率
3.70%
发文量
297
审稿时长
7.6 weeks
期刊介绍: Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. The journal publishes practical, timely, and relevant clinical and basic science research articles which address any aspect of urologic oncology. Each issue comprises original research, news and topics, survey articles providing short commentaries on other important articles in the urologic oncology literature, and reviews including an in-depth Seminar examining a specific clinical dilemma. The journal periodically publishes supplement issues devoted to areas of current interest to the urologic oncology community. Articles published are of interest to researchers and the clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.
期刊最新文献
Spatial immunophenotyping of tumor-associated macrophages predicts prognostic outcomes in clear cell renal cell carcinoma Combined and individual effects of neoadjuvant chemotherapy and lymph node dissection on survival in non–muscle-invasive bladder cancer undergoing radical cystectomy Is More Better? Evaluating Neoadjuvant Chemotherapy Cycles Before Surgery for High-Risk Upper Tract Urothelial Carcinoma Real-world treatment sequences and overall survival in metastatic bladder cancer: The STATES-Bladder study Real-world functional and oncologic outcomes of prostate gland ablation vs. standard of care therapies for localized prostate: A retrospective cohort study using the TriNetX database
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1